Short communication cytochrome P450 2S1 is reduced by NADPH-cytochrome P450 reductase

Drug Metabolism and Disposition

Volumn 39, Issue 6, 2011, Pages 944-946

  Xiao, Yi ^a   Shinkyo, Raku ^a   Guengerich, F Peter ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BANOXANTRONE; CYTOCHROME P450; CYTOCHROME P450 2S1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE FERRIHEMOPROTEIN REDUCTASE; UNCLASSIFIED DRUG; ANTHRAQUINONE DERIVATIVE; CYP2S1 PROTEIN, HUMAN; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE;

ANAEROBIC METABOLISM; ARTICLE; CATALYSIS; CONTROLLED STUDY; ELECTRON TRANSPORT; ENZYME ACTIVITY; ENZYME KINETICS; EXPRESSION VECTOR; HUMAN; ISOMERIZATION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT; AEROBIC METABOLISM; ANAEROBIC GROWTH; ANIMAL; CHEMISTRY; ENZYMOLOGY; ESCHERICHIA COLI; GENETICS; METABOLISM; OXIDATION REDUCTION REACTION;

AEROBIOSIS; ANAEROBIOSIS; ANIMALS; ANTHRAQUINONES; CYTOCHROME P-450 ENZYME SYSTEM; ELECTRON TRANSPORT; ESCHERICHIA COLI; HUMANS; NADPH-FERRIHEMOPROTEIN REDUCTASE; OXIDATION-REDUCTION; OXYGEN; RATS;

EID: 79956120717     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.111.039321     Document Type: Article

References (21)

1. Bui PH and Hankinson O (2009) Functional characterization of human cytochrome P450 2S1 using a synthetic gene-expressed protein in Escherichia coli. Mol Pharmacol 76:1031-1043.
2. Bui PH, Hsu EL, and Hankinson O (2009) Fatty acid hydroperoxides support cytochrome P450 2S1-mediated bioactivation of benzo[a]pyrene-7,8-dihydrodiol. Mol Pharmacol 76:1044-1052.
3. Bui P, Imaizumi S, Beedanagari SR, Reddy ST, and Hankinson O (2011) Human CYP2S1 metabolizes cyclooxygenase- and lipoxygenase-derived eicosanoids. Drug Metab Dispos 39:180-190.
4. Chang MS, Boeglin WE, Guengerich FP, and Brash AR (1996) Cytochrome P450-dependent transformations of 15R- and 15S-hydroperoxyeicosatetraenoic acids: stereoselective formation of epoxy alcohol products. Biochemistry 35:464-471.
5. Gigon PL, Gram TE, and Gillette JR (1969) Studies on the rate of reduction of hepatic microsomal cytochrome P-450 by reduced nicotinamide adenine dinucleotide phosphate: effect of drug substrates. Mol Pharmacol 5:109-122.
6. Guengerich FP, Ballou DP, and Coon MJ (1976) Spectral intermediates in the reaction of oxygen with purified liver microsomal cytochrome P-450. Biochem Biophys Res Commun 70:951-956.
7. Guengerich FP and Bartleson CJ (2007) Analysis and characterization of enzymes and nucleic acids, in Principles and Methods of Toxicology (Hayes AW ed) pp 1981-2048, CRC Press, Boca Raton, FL.
8. Guengerich FP and Johnson WW (1997) Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in absence of substrate and variations among cytochrome P450 systems. Biochemistry 36:14741-14750. (Pubitemid 27524395)
9. Guengerich FP, Krauser JA, and Johnson WW (2004) Rate-limiting steps in oxidations catalyzed by rabbit cytochrome P450 1A2. Biochemistry 43:10775-10788. (Pubitemid 39096720)
10. Guengerich FP, Tang Z, Salamanca-Pinzón SG, and Cheng Q (2010) Characterizing proteins of unknown function: orphan cytochrome P450 enzymes as a paradigm. Mol Interv 10:153-163.
11. Guengerich FP, Tang Z, Cheng Q, and Salamanca-Pinzón SG (2011) Approaches to deorphanization of human and microbial cytochrome P450 enzymes. Biochim Biophys Acta 1814:139-145.
12. Hanna IH, Teiber JF, Kokones KL, and Hollenberg PF (1998) Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities. Arch Biochem Biophys 350:324-332. (Pubitemid 28368660)
13. Mansuy D, Bartoli JF, and Momenteau M (1982) Alkane hydroxylation catalyzed by metalloporphyrins: evidence for different active oxygen species with alkylhydroperoxides and iodosobenzene as oxidants. Tetrahed Lett 23:2781-2784.
14. Nishida CR, Lee M, and de Montellano PR (2010) Efficient hypoxic activation of the anticancer agent AQ4N by CYP2S1 and CYP2W1. Mol Pharmacol 78:497-502.
15. Ortiz de Montellano PR (1995) Oxygen activation and reactivity, in Cytochrome P450 Structure, Mechanism, and Biochemistry (Ortiz de Montellano PR ed), pp 245-303, Plenum Press, New York.
16. Patil PV and Ballou DP (2000) The use of protocatechuate dioxygenase for maintaining anaerobic conditions in biochemical experiments. Anal Biochem 286:187-192.
17. Rivera SP, Saarikoski ST, and Hankinson O (2002) Identification of a novel dioxin-inducible cytochrome P450. Mol Pharmacol 61:255-259. (Pubitemid 34112798)
18. Rivera SP, Wang F, Saarikoski ST, Taylor RT, Chapman B, Zhang R, and Hankinson O (2007) A novel promoter element containing multiple overlapping xenobiotic and hypoxia response elements mediates induction of cytochrome P4502S1 by both dioxin and hypoxia. J Biol Chem 282:10881-10893. (Pubitemid 47100738)
19. Swaine DJ, Loadman PM, Bibby MC, Graham MA, and Patterson LH (2000) High-performance liquid chromatographic analysis of AQ4N, an alkylaminoanthraquinone N-oxide. J Chromatogr B Biomed Sci Appl 742:239-245. (Pubitemid 30331041)
20. Weiss RH, Arnold JL, and Estabrook RW (1987) Transformation of an arachidonic acid hydroperoxide into epoxyhydroxy and trihydroxy fatty acids by liver microsomal cytochrome P-450. Arch Biochem Biophys 252:334-338. (Pubitemid 17006025)
21. Wu ZL, Sohl CD, Shimada T, and Guengerich FP (2006) Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1. Mol Pharmacol 69:2007-2014. (Pubitemid 43894320)